Logo image
Update in treatment options in pulmonary hypertension
Journal article   Peer reviewed

Update in treatment options in pulmonary hypertension

Manreet K. Kanwar, Thenappan Thenappan and Jean-Luc Vachiéry
The Journal of heart and lung transplantation, v 35(6), pp 695-703
01 Jun 2016
PMID: 26952200
url
https://doi.org/10.1016/j.healun.2016.01.020View
Published, Version of Record (VoR) Restricted

Abstract

clinical trials pulmonary hypertension pulmonary vascular disease treatment updates
Significant developments have occurred in the field of pulmonary hypertension (PH) in the past 2 years, especially in terms of treatment options available. These include: approval of new drugs; evidence for use of initial combination therapies in pulmonary arterial hypertension; approved drugs for use in chronic thromboembolic disease not amenable to, or persistent after surgical thromboendarterectomy; and ongoing clinical trials in PH related to left heart disease and hypoxia. The field continues to evolve and address the challenges in treatment of this multifaceted disease with the aim to provide novel solutions and meet the needs of a growing population with PH. This has led to an extensive body of literature, ranging from case series to prospective, multicenter clinical trials, which will enhance the future of patient outcomes in PH. This contemporary review highlights the key articles in treatment updates for PH for the years 2013 to 2015.

Metrics

5 Record Views
20 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Cardiac & Cardiovascular Systems
Respiratory System
Surgery
Transplantation
Logo image